BREA, California (TheStreet) -- Danaher (DHR) reached an agreement to buy Beckman Coulter (BEC), a maker of biomedical testing equipment, for $83.50 a share in cash, or about $6.8 billion including assumed debt.
The purchase price is a 46% premium over Beckman Coulter's closing price of $57.09 on Dec. 9, 2010, before rumors of an acquisition first surfaced, the companies said in a statement Monday.
The transaction is expected to be completed in the first half of 2011.
-- Written by Joseph Woelfel
>To contact the writer of this article, click here: Joseph Woelfel
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV